Navigation Links
La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert
Date:12/10/2009

La Jolla Pharmaceutical value debate is raging on as investors consider the facts in the merger agreement with Adamis Pharmaceuticals Corp. Some investors have stated in a TapeBeat.Com discussion thread that the value is to be decided by the market while other say simple math proves the value was set in the merger agreement.

New York, NY (PRWEB) December 10, 2009 -- TapeBeat.Com the news and research portal for the serious investor has noted an extreme range of disagreement among investors and traders about the value of La Jolla Pharmaceutical Company (LJPC) and Adamis Pharmaceuticals Corp (ADMP). To say it's a disagreement is putting it mildly. Some investors have been clearly inferring it would be better to let the stock fly even if simple math may prove the value set at a much lower range and leave 'others holding the bag'. Traders at TapeBeat.Com freely share information and research and would like the facts, whatever they are, brought to light and to make sure full due diligence is available to all. A discussion thread was started on TapeBeat.Com which spilled over into other boards where some put the value of La Jolla between .04 and .07 (xluckystrike21 and others). LJPC closed at .25 in after hours trading after a 2 day run up of about 280%. So is the value less than a dime or more than a quarter for La Jolla (LJPC). Could it be possible that so many are wrong and the better value is to buy Adamis Pharmaceuticals Corp (ADMP) shares?

The discussion thread that was started on the La Jolla Pharmaceutical Company (LJPC) Merger with Adamis Pharmaceuticals Corp (ADMP) begins:

People have it wrong....it is a REVERSE MERGER- ADMP is merging into and becoming LJPC. In reverse mergers, a company with no business merges with a company who has business.....LPJC has not
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. La Jolla Institute for Allergy & Immunology Wows With New Website
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 
(Date:9/17/2014)... 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY ... sell shares of its Common Stock and Series A ... offerings.  The Series A Convertible Preferred Stock is non-voting ... that conversion will be prohibited if, as a result, ... than 4.99% of the Common Stock then outstanding. As ...
(Date:9/17/2014)... MARIETTA, Ga. , Sept. 17, 2014  MiMedx ... integrated developer, processor and marketer of patent protected ... membrane, announced today the publication of another peer-reviewed clinical ... " A Multi-center Randomized Controlled Clinical Trial ...   Amnion/Chorion Membrane Allografts and Multi-layer Compression Therapy ...
(Date:9/17/2014)... & Rockville, MD (PRWEB) September 17, 2014 ... a Small Business Innovation Research (SBIR) grant to support ... The award will provide ITI with approximately $255,000 over ... nuts, a leading cause of food allergy, affect over ... of anaphylaxis behind peanut allergy. Tree nut exposure is ...
(Date:9/17/2014)... LAUDERDALE, Fla. , Sept. 17, 2014 Alternative ... an agreement to form a Special Purpose Vehicle in partnership ... based Jatropha centric agro energy company. The SPV shall be ... registered entity with AFAI as majority shareholder. The SPV shall ... Africa , particularly Ethiopia . ...
Breaking Biology Technology:Oncothyreon Announces Proposed Public Offerings 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3
... March 25 Accera, Inc., a biotechnology company delivering ... announced that the company will be participating at two ... and CEO, will speak at the 2nd Annual BIO ... at the Sheraton Boston Hotel in Boston, MA. On ...
... 25 Shire plc (LSE: SHP, NASDAQ:, SHPGY ... Report and Accounts in respect of the year ended ... has previously announced unaudited full,year 2008 results, prepared in ... year earnings announcement on February 19,2009. , ...
... JOSEPH, Mich., and RALEIGH, N.C., March 25 ... grade televisions and communications solutions to hospitals, today announced ... part of the health system,s strategy to enhance the ... with Lakeland,s vision of improving the hospital experience by ...
Cached Biology Technology:Accera, Inc. to Present at Upcoming Investor Conferences 2Publication of Shire plc's Annual Report 2008 2Publication of Shire plc's Annual Report 2008 3Publication of Shire plc's Annual Report 2008 4Publication of Shire plc's Annual Report 2008 5Publication of Shire plc's Annual Report 2008 6Publication of Shire plc's Annual Report 2008 7Publication of Shire plc's Annual Report 2008 8Publication of Shire plc's Annual Report 2008 9Publication of Shire plc's Annual Report 2008 10Publication of Shire plc's Annual Report 2008 11Publication of Shire plc's Annual Report 2008 12Publication of Shire plc's Annual Report 2008 13Publication of Shire plc's Annual Report 2008 14Publication of Shire plc's Annual Report 2008 15Publication of Shire plc's Annual Report 2008 16Publication of Shire plc's Annual Report 2008 17Publication of Shire plc's Annual Report 2008 18Publication of Shire plc's Annual Report 2008 19Publication of Shire plc's Annual Report 2008 20Publication of Shire plc's Annual Report 2008 21Publication of Shire plc's Annual Report 2008 22Publication of Shire plc's Annual Report 2008 23Publication of Shire plc's Annual Report 2008 24Publication of Shire plc's Annual Report 2008 25Publication of Shire plc's Annual Report 2008 26Publication of Shire plc's Annual Report 2008 27Publication of Shire plc's Annual Report 2008 28Publication of Shire plc's Annual Report 2008 29Publication of Shire plc's Annual Report 2008 30Publication of Shire plc's Annual Report 2008 31Publication of Shire plc's Annual Report 2008 32Publication of Shire plc's Annual Report 2008 33TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience 2TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience 3
(Date:9/16/2014)... biology taught us that we inherit certain traits from ... could change how these genes play out by taking ... That,s exactly what a team of researchers at ... through their research of epigenetics research. , Epigenetics ... modifying DNA and histone proteins, which prevent permanent mutations ...
(Date:9/16/2014)... has its own bacterial identity. That,s the conclusion of ... who studied the genetic fingerprints of bacteria on 57 ... "This study demonstrates for the first time that host ... strategies possess very different microbial communities on their leaves," ... researcher in the UO,s Institute of Ecology and Evolution ...
(Date:9/16/2014)... diameter chunk of rock hit the Yukatan peninsula near the ... of 100 teratons of TNT. It left a crater more ... earthquakes and volcanism are widely accepted to have wiped out ... mammals. But what happened to the plants on which the ... the University of Arizona reveals that the meteorite impact that ...
Breaking Biology News(10 mins):Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3
... that the bacterium that causes dysentery uses a 'sword ... research published today in Science, the team from Imperial ... the bacteria which causes dysentery, is able to invade ... , They found that shigella was able to infect ...
... 99 percent of the genes in the adult body. That's ... of bacteria that normally live on and in us. , ... to researchers at the School of Medicine will help fill ... for isolating, sequencing and analyzing the genomes of "friendly" bacteria ...
... in the journal Blood, Yale scientists identify the molecular triggers ... expand into large populations of malignant lymphocytes. , CTCL is ... blood cells of the immune system. Finding CTCL triggering factors ... Director of the Yale Cancer Center, and professor and chair ...
Cached Biology News:W.M. Keck Foundation funds study of friendly microbes 2W.M. Keck Foundation funds study of friendly microbes 3Source of molecular triggers in cutaneous T cell lymphoma identified 2
HOXC11 Antibody...
HOXC11 Antibody...
PPOX Immunogen: PPOX (AAH02357, 378 a.a. ~ 478 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: